Synthetic peptides as Malaria vaccines

Malaria: Molecular and Clinical Aspects

Volumn , Issue , 1999, Pages 495-540

  Nardin, Elizabeth ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 2042539038     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (244)

1. Aggarwal, A., Kumar, S., Jaffe, R., Hone, D., Gross, M. and Sadoff, J. (1990). Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells. J. Exp. Med., 172, 1083–1090.
2. Ahlborg, N., Iqbal, J., Hansson, M., Uhlen, M., Mattei, D., Perlmann, P. et al. (1995). Immunogens containing sequences from antigen Pf332 induce Plasmodium falciparum reactive antibodies which inhibit parasite growth but not cytoadherence. Parasite Immunol., 17, 341–352.
3. Ahlborg, N. (1995). Synthesis of a diepitope multiple antigen peptide containing sequences from two malaria antigens using Fmoc chemistry. J. Immunol. Meth. 179, 269–275.
4. Ahlers, J.D., Takeshita, T., Pendleton, CD. and Berzofsky, J.A. (1997). Enhanced immunogenicity of HIV-1 vaccine construct by modification of the native peptide sequence. PNAS, 94, 10856–10861.
5. Aichele, P. Hengartne H., Zinkernagel, R.M. and Schulz, M. (1990). Antiviral cytotoxic T cell response induced by in vivo priming with a free synthetic peptide. J. Exp. Med., 171, 1815–1820
6. Aichele, P., Brduscha-Riem, K., Zinkernagel, R.M., Hengartner, H. and Pircher, H. (1995). T cell priming versus T cell tolerance induced by synthetic peptides. J. Exp. Med., 182, 261–266.
7. Aidoo, M., Lalvani, A Allsopp, C, Plebanski, M., Meisner, S., Krausa, P. et al. (1995). Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet, 345, 1003–1007.
8. Ak, M., Bower, J.H., Hoffman, S.L., Sedegah, M., Lees, A., Carter, M. et al. (1993). Monoclonal antibodies of three different immunoglobulin G isotypes produced by immunization with a synthetic peptide or native protein protect mice against challenge with Plasmodium yoelii sporozoites. Infect. Immun., 61, 2493–2497.
9. Alexander, J., Sidney, J., Southwood, S., Ruppert, J., Oseroff, C, Maewal, A. et al. (1994) Development of high potency universal DR-restricted helper epitopes by modification ofhigh affinity DR-blocking peptides. Immunity, 1, 751–761.
10. Allsopp, C.E., Plebanski, M., Gilbert, S., Sinden, R.E., Haris, S., Frankel, G. et al. (1997). Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization. Eur. J. Immunol, 26, 1951–1959
11. Arnot, D.E., Barnwell, J.W., Tam, J.P., Nussenzweig, V., Nussenzweig, R.S. et al. (1985). Circumsporozoite protein of Plasmodium vivax: Gene cloning and characterization of the immunodominant epitope. Science, 230, 815–816.
12. Arrowood, M.J., Sterling, CR. and Healey, M.C (1991). Immunofluorescent microscopical visualization of trails left by gliding Crypptosporodium parvum sporozoites.J. Parasitol., 77, 315–317.
13. Atherton, E. and Sheppard, R.C (1985). Solid-phase peptide synthesis using Noc-fluorenylmethoxycarbonyl amino acid pentafluorophenyl esters. J. Chem. Soc. Chem. Commun., 3, 165–166.
14. Beier, J. Perkins, P.V., Onyango, F.K., Gargan, T.P., Oster, CN., Whitmire, R.E. et al. (1990). Characterization of malaria transmission by Anopheles (Diptera:Culeidae) in western Kenya in preparation for malaria vaccine trials. J. Med. Entomol., 27, 570–577.
15. BenMohamed, L., Gras-Masse, H., Tartar, A., Daubersies, P., Brahimi, K., Bossus, M. et al. (1997). Lipopeptide immunization without adjuvant induces potent and long-1 as ting, B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees. Eur. J. Immunol., 27, 1242–1253.
16. Bittle, J.L., Houghten, R.A., Alexander, H., Shinnick, T.M., Sutcliff, J.G., Lemer R.A et al. (1982). Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature, 298, 30–33.
17. Blum-Tirouvanziam, U., Beghdadi-Rais, C, Roggero, M.A., Valmori, D., Bertholet, S., Bron, C et al. (1994). Elicitation of specific cytotoxic T cells by immunization with malaria soluble synthetic polypeptides, J. Immunol., 154, 3922–3931.
18. Blum-Tirouvanziam, U., Servis, C, Habluetzel, A., Valmori, D., Men, Y., Esposito, F et al. (1995). Localization of HLA-DQ restricted T cell epitopes in the circumsporozoite protein of Plasmodium falciparum. J. Immunol., 154, 3922–3931.
19. Borges, E., Wiesmuller, K.H., Jung, G. and Walden, P. (1994). Efficacy of synthetic vaccines in the induction of cytotoxic T lymphocytes. Comparison of the costimulating support provided by helper T cells and lipoamino acid. J. Immunol. Meth., 173, 253–263.
20. Bourgault, I, Chirat, F, Tartar, A., Leby, J.P, Guillet, J.G. and Venet, A. (1994). Simian immunodeficiency virus as a model for vaccination against HIV. Induction in rhesus macaques of GAG- or NEF-specific cytotoxic T lymphocytes by lipopeptides. J. Immunol., 152, 2530–2537.
21. Boyd, M.F. and Kitchen, S.F. (1936). Is the acquired heterologous immunity to Plasmodium vivax equally effective against sporozoites and trophozoites? Am. J. Trop. Med., 16, 317–322.
22. Bray, R.S. (1976). Vaccination against Plasmodium falciparum: A negative result. Trans. Roy. Soc. of Trop. Med. Hyg., 70, 258.
23. Calvo-Calle, J.M., Nardin, E.H., Clavijo, P., Boudin, C., Stuber, D., Takacs, B. et al. (1992). Recognition of different domains of the Plasmodium falciparum CS protein by the sera of naturally-infected individuals compared with those of sporozoite-immunized volunteers. J. Immunol., 149, 2695–2701.
24. Calvo-Calle, J. M., de Oliveira, G.A., Clavijo, P., Maracic, M., Tam, J. P., Lu, Y. A. et al. (1993). Immunogenicity of multiple antigen peptides containing B and non-repeat T cell epitopes of the circumsporozoite protein of Plasm odium falciparum. J. Immunol., 150, 1403–1412.
25. Calvo-Calle, J.M., Hammer, J., Sinigaglia, F, Clavijo, P., Moya-Castro, Z.R. and Nardin, E.H. (1997). Binding of malaria T cell epitopes to DR and DQ molecules in vitro correlates with immunogenicity in vivo. Identification of a universal T cell epitope in the Plasmodium falciparum circumsporozoite protein. J. Immunol., 159, 1362–1373.
26. Cerami, C., Frevert, U., Sinnis, P., Takacs, B., Clavijo, P., Santos, M.J. etal. (1992). The basolateral domain of the hepatocyte plasma membrane bears receptors for the circumsporozoite protein of Plasmodium falciparum sporozoites. Cell, 70, 1021–1033.
27. Charoenvit, Y, Leef, M., Yuan, L., Sedegan, M. and Beaudoin, R. (1987). Characterization of Plasmodium yoelii monoclonal antibodies directed against stage specific sporozoite antigens. Infect. Immun., 55, 604608.
28. Charoenvit, Y., Mellouk, S., Cole, C, Bechara, R., Leef, M.F, Sedegah, M. et al. (1991a). Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites. J. Immunol., 146, 1020–1025.
29. Charoenvit, Y., Collins, W.E., Jones, T.R., Millet, P., Yuan, L., Campbell, G.H. et al. (1991b). Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence. Science, 251, 668–671.
30. Charoenvit, Y., Fallarme, V, Roger, W.O., Sacci, J.B., Kaur, M., Aguiar, J.C. et al. (1997). Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B cell epitopes. Infect. Immun., 65, 3430–3437.
31. Chattergee, S., Sharma, P., Kumar, S. and Chauhan, VS. (1995). Fine specificity of immune responses to epitopic sequence in synthetic peptides containing B and T epitopes from the conserved Plasmodium falciparum blood stage antigens. Vaccine, 13, 1474–1481.
32. Chen, D.H., Tigelaar, R.E. and Weinbaum, F (1977). Immunity to sporozoite-induced malaria infection in mice. I The effect of immunization of T and B cell-deficient mice. J. Imm unol., 118, 1322–1327.
33. Clyde, D.F., Most, H., McCarthy, V and Vanderberg, J.P. (1973a). Immunization of man against sporozoite induced falciparum malaria. Am. J. Med. Sci., 266, 169–177.
34. Clyde, D.E, McCarthy, V.C., Miller, R.M., and Hornick, R.B. (1973b). Specificity of protection of man immunized against sporozoite induced falciparum malaria. Am. J. Med. Sci., 266, 398–403.
35. Clyde, D.E, McCarthy, V., Miller, R.M and Woodward, W.E. (1975). Immunization of man against falciparum and vivax malaria by use of attenuated sporozoites. Am. J. Trop. Med. Hyg., 24, 397–401.
36. Cochrane, A.H., Aikawa, M., Jeng, M. and Nussenzweig, R.S. (1976). Antibody-induced ultrastructural changes of malarial sporozoites. J. Immunol., 116, 859–867.
37. Cochrane, A.H., Santoro, F., Nussenzweig, Y, Gwadz, R.W. and Nussenzweig R.S. (1982). Monoclonal antibodies identify the protective antigens of sporozoites of Plasmodium knowlesi. PNAS, 79, 5651–5655.
38. Collins, WE., Sullivan, J.S., Morris, C.L., Galland, G.G., Jue, D.L., Fang, S. et al. (1997). Protective immunity induced in squirrel monkeys with a multiple anitgen construct against the circumsporozoite protein of Plasmodium vivax. Am. J. Trop. Med. Hyg., 56, 200–210.
39. Cowan, G., Krishna, S., Crisanti, A. and Robson, K. (1992). Expression of thrombospondin-related anonymous protein in Plasmodium falciparum sporozoites. Lancet, 339, 1412–1413.
40. Cryz, S., Davis, S.S., Gregoriadis, G., Grimaud, J.-A., Kourilsky, P., Selkirk, M. E. et al. (1996). Vaccine delivery systems. Vaccine, 14, 665–691.
41. Dame, J.B., Williams, J.L., McCutchan, T.E, Weber, J.L., Wirtz, R.A., Hockmeyer, WT et al. (1984). Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science, 225, 593–99.
42. Danforth, H.D., Aikawa, M., Cochrane, A. and Nussenzweig, R.S. (1980). Sporozoites of mammalian malaria: attachment to and interiorization and fate within macrophages. J. Protozool., 27, 193–202.
43. Darcy, F., Maes, P., Gras-Masse, H., Auriault, C., Bossus, M., Deslee, D. et al. (1992). Protection of mice and nude rats against toxoplasmosis by a multiple antigenic peptide construction derived from Toxoplasma gondii p30 anti gen. J. Imm unol., 149, 3636–3641.
44. Defoort, J.P., Nardelli, B., Huang, W., Ho, D.D. and Tam, J.P. (1992). Macromoleeular assemblage in the design of a synthetic AIDS vaccine. PNAS, 89, 3879–3883.
45. De Groot, A., Johnson, A, Maloy, W., Quakyi, I., Riley, E., Menon, A. et al. (1989). Human T cell recognition of polymorphic epitopes from malaria circumsporozoite protein. J. Immunol., 142, 4000–4005.
46. de Oliveira, G.A, Clavijo, P., Nussenzweig, RS. and Nardin, E.H. (1994). Immunogenicity of an alum-adsorbed synthetic multiple antigen peptide based on B- and T-cell epitopes of the Plasmodium falciparum CS protein: Possible vaccine application. Vaccine, 12, 1012–1017.
47. Del Giudice, G., Cooper, J.A, Merino, J., Verdini, AS., Pessi, A, Togna, R. et al. (1986). The antibody response in mice to carrier-free synthetic polymers of Plasmodium falciparum circumsporozotie repetitive epitope is I-Ab restricted: possible implications for malaria vaccine. Immunol., 137, 2952–2955.
48. Del Giudice, G., Tougne, C., Louis, J.A, Lambert, P-H., Bianchi, E., Bonelli, F et al. (1990). A multiple antigen peptide from the repetitive sequence of the Plasmodiummalariae circumsporozoite protein induces a specific antibody response in mice of various H-2 haplotypes. Eur. Immunol., 20, 1619–1622.
49. del Guercio, M.F., Alexander, J., Kubo, R.T., Arrhenius, T., Maewal, A., Appella, E. et al. (1997). Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE), for antibody responses in vivo. Vaccine, 15, 441–448.
50. Deres, K., Schild, H., Wiesmuller, K.-H., Jung, G. and Rarnmensee, H.-G. (1989). In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine. Nature, 342, 561–564.
51. DiJohn, D., Torres, J.R., Murillo, J., Herrington, D.A., Wasserman, S.S., Cortesia, M.J. et al. (1989). Effect of priming with carrier on response to conjugate vaccine. Lancet, 2, 1415–1418.
52. Doolan, D.L., Saul, AJ. and Good, M.F. (1992). Geographically restricted heterogeneity of the Plasmodium falciparum circumsporozoite protein: Relevance for vaccine development. Infect. Immun., 60, 675–682.
53. Druilhe, P., Pradier, O., Marc, J.P., Miltgen, E, Mazier, D. and Parent, G. (1986). Levels of antibodies to Plasmodium falciparum sporozoite surface antigens reflect malaria transmission rates and are persistent in the absence of reinfection. Infect. Immun., 53, 393–397.
54. Edelman, R., Hoffman, S.L., Davis, J.R., Beier, M., Sztein, M.B., Losonsky, G. et al. (1993). Long-term persistence of sterile immunity in a volunteer immunized with X-irradiated Plasmodium falciparum sporozoites. J. Infect. Dis., 168, 1066–1070.
55. Eichinger, D.J., Arnot, D.E., Tam, J.P., Nussenzweig, V. and Enea, V. (1986). Circumsporozoite protein of Plasmodium berghei: Gene cloning and identification of the immunodominant epitopes. Mol. Cell. Biol., 6, 3965–3972.
56. Egan, J.E., Weber, J.L., Ballou, W.R., Hollingdale, M.R., Majarian, W.R., Gordon, D.M. et al. (1987). Efficacy of murine malaria sporozoite vaccine: Implications for human vaccine development. Science, 236, 453456.
57. Egan, J.E., Hoffman, S.L., Haynes, J.D., Sadoff, J.C., Schneider, I., Grau, G.E. et al. (1993). Humoral immune responses in volunteers immunized with radiation attenuated P. falciparum sporozoites. Am. J. Trop. Med. Hyg., 49, 166–173.
58. Entzeroth, R., Zgrzebski, G. and Dubremetz, J.-F. (1989). Secretion of trails during gliding motility of Eimf'ria nieshulzi (Apicomplexa, Coccidia) sporozoites visualized by a monoclonal antibody and immuno gold-silver enhancement. Parasitol. Res., 76,174–175.
59. Etlinger, H.M., Felix, A.M., Gillessen, D., Heimer, E.P., Just, M., Pink, J.R.L. et al. (1988). Assessment in humans of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite Plasmodium falciparum. J. Immunol., 140, 626–633.
60. Etlinger, H., Gillessen, D. Lahm, H-W., Matile H., Schonfeld, H-J. and Trzeciak, A. (1990). Use of prior vaccinations for the development of new vaccines. Science, 249, 423–425.
61. Fayolle, C., Deriaud, E. and Leclerc, C. (1991). In vivo induction of cytolytic T cell response by a free synthetic peptide requires CD4+ T cell help. J. Immunol., 147, 4069–4073.
62. Feltkamp, M.C., Smits, H.L., Vierboom, M.P., Minnaar, R.E, de Jongh, B.M., Drijfhout, J.W. et al. (1993). Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor induced by human papillomavirus type 16-transformed cells. Eur. J. Immunol., 23, 2242–2249.
63. Ferreira, A., Schofield, L., Enea, v., Schellekens, H., van der Meide, P, Collins, W.E. et al. (1986). Inhibition of development of exoerythrocytic forms of malaria parasites by gamma-interferon. Science, 232, 881884.
64. Franke, E.D., Corradin, G. and Hoffman, S.L. (1997). Induction of protective CTL responses against tile Plasmodium yo elii circumsporozoite protein by immunization with peptides. Imm unol., 159, 34243433.
65. Frevert, U., Sinnis, P., Cerami, C., Shreffler, W., Takacs, B. and Nussenzweig, V. (1993). Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes. J. Exp. Med., 177, 1287–1298.
66. Fries, L.F., Gordon, D.M., Richards, R.L., Egan, J.E., Hollingdale, M.R., Gross, M. et al. (1992). Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy. PNAS, 89, 358--362.
67. Galinski, M.R., Arnot, E., Cochrane, A.H., Barnwell, J.W, Nussenzweig, RS. and Enea, V. (1987). The circumsporozoite gene of Plasmodium cynomolgi complex. Cell, 48, 311–319.
68. Good, M.F., Berzofsky, J.A., Maloy, W.L., Hayashi, Y, Fujii, N., Hockmeyer, W.T. et al. (1986). Genetic control of the immune response in mice to Plasmodium falciparum sporozoite vaccine. Widespread non-responsiveness to single malaria T epitope in highly repetitive vaccine. J. Exp. Med., 164, 655–660.
69. Good, M.F., Maloy, W.L., Lunde, M.N., Margalit, H., Cornette, J.L., Smith, G.L. et al. (1987). Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein. Science, 235, 1059–1062.
70. Good, M.F., Pombo, D., Quakyi, LA., Riley, E M., Houghten, R.A., Menon, A. et al. (1988). Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immuno dominant T-cell domains map to the polymorphic regions of the molecule. PNAS, 85, 1199–1203.
71. Gorse, G.J., Keefer, M.C., Belshe, R.B., Matthews, T.J., Forrest, B.C., Hsieh, R.H. et al. (1996). A dose-ranging study of a prototoype synthetic HIV-l MN V3 branched peptide vaccine. J. Infect. Dis., 173, 330–339.
72. Grillot, D., Michel, M., Muller, I., Tougne, C., Renia, L., Mazier, D. et al. (1990). Immune responses to defined epitopes of the circumsporozoite protein of the murine malaria parasite, Plasmodium yoelii. Eur. J. Immunol., 30, 1215–122.
73. Gupta, R.K. and Siber, G. (1995). Adjuvants for human vaccines — current status, problems and future prospects. Vaccine, 13, 1263–1276.
74. Gwadz, R.W., Cochrane, A.H., Nussenzweig, V. and Nussenzweig, RS. (1979). Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites. Bull. W.H.O., 57(Suppl.), 165–173.
75. Herrera, S., Escobar, P., de Plata, C., Avila, G.I., Corradin, G. and Herrera, M.A. (1992). Human recognition of T cell epitopes on the Plasmodium vivax circumsp orozoite protein. J. Imm unol., 148, 3986–3990.
76. Herrera, S., DePlata, C., Gonzalez, J.M., Perlaza, B.L., Bettens, P., Corradin, G. et al. (1997). Antigenicity and immunogenicity of multiple antigen peptides (MAP) containing Plasmodium vivax CS epitopes in Aotus monkeys. Parasite Imm unol., 19, 161–170.
77. Herrington, D.A., Clyde, D.F., Losonsky, G., Cortesia, M., Murphy, J.R., Davis, J. et al. (1987). Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodiumfalciparum sporozoites. Nature. 328, 257–259.
78. Herrington, D., Davis, J., Nardin, E., Beier, M., Cortese, J., Eddy, H. et al. (1991). Successful immunization of humans with irradiated malaria sporozoites: Humoral and cellular responses of the protected individuals. Am. J. Trop. Med. Hyg., 45, 539–547.
79. Herzenberg, L.A., Tokuhisa, T. and Herzenberg, LA (1980). Carrier priming leads to hapten specific suppression. Nature, 285, 664–667.
80. Hill, A.V., Elvin, J., Willis, AC., Aidoo, M., Allsopp, C.E., Gotch, F.M. et al. (1992). Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature, 360, 434–439.
81. Hioe, C.E., Qiu, H., Chend, P.D., Bian, Z., Li, M.-L., Li, J. et al. (1996). Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptides. Vaccine, 14, 412–418.
82. Hoffman S.L., Wi star, R., Ballou, WR., Hollingdale, M.R., Wirtz, R.A, Schneider, I. et al. (1986). Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum. New Eng. J. Med., 315, 601–606.
83. Hoffman, S. Oster, C., Mason, C., Beier, J., Sherwood, J., Ballou, W.R. et al. (1989). Human lymphocyte proliferative response to a sporozoite T cell epitope correlates with resistance to falciparum malaria. J. Immunol., 142, 1299–1303.
84. Hoffman, S., Isenbarger, D., Long, G., Sedegah, M., Szarfman, A., Waters, L. et al. (1989). Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes. Science, 244, 1078–1081.
85. Hollingdale, M.R., Zavala, F., Nussenzweig, R.S. and Nussenzweig, V (1982). Antibodies to the protective antigen of Plasm odium berghei sporo zoites prevent entry into cultured hepatoma cells. J. Immunol., 128, 1929–1930.
86. Hollingdale, M.R., Nardin, E.H., Tharavanij, S., Schwartz, AL. and Nussenzweig, R.S. (1984). Inhibition of entry of Plasmodiumfalciparum and P. vivax sporozoites I nto cultured cells; an in vitro assay of protective antibodies. J. Immunol., 132, 909–913.
87. Kast, W.M., Roux, L., Curren, J., Blorn, H.J., Voordouw, A, C., Meloen, R.H. et al. (1991). Protection against lethal Sendai virus infection by in vivo priming of virus specific cytotoxic T lymphocytes with a free synthetic peptide. PNAS, 88, 2283–2287.
88. Kensil, C.R., Patel, U., Lennick, M. and Marciani, D. (1991). Separation and characterization of saponins with adjuvant activity from Quillaja saponaria molina cortex. J. Immunol., 146, 431–437.
89. Khan, A.M. and Vanderberg, J.P. (1991). Role of host cellular response in differential susceptibility of nonimmunized BALB/c mice to Plasmodium berghei and Plasmodium yoelii sporozoites. Infect. Immun., 59, 2529–2534.
90. Khusmith, S., Charoenvit, Y., Kumar, S., Sedegah, M., Beaudoin, R.L. and Hoffman, S.L. (1991). Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein. Science, 252, 715–718.
91. Khusmith, S., Sedegah, M. and Hoffman, S.L. (1994). Complete protection against Plasmodium yoelii by adoptive transfer of CD8+ cytotoxic T cell clone recognizing sporozoite surface protein 2. Infect. Immun., 62, 2979–2983.
92. Klotz, E, Scheller, L., Seguin, M., Kumar, N., Marietta, M.A., Green, SJ. et al. (1995). Co-localization of inducible-nitric oxide synthase and Plasmodium berghei in hepatocytes from rats immunized with irradiated sporozoites. J. Immunol., 154, 3391–3395.
93. Kovacsovics-Bankowski, M. and Rock, K.L. (1995). A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science, 267, 243–246.
94. Krzych, U., Lyon, J.A., Jareed, T., Schneider, L, Hollingdale, M.R., Gordon, D.M. et al. (1995). T lymphocytes from volunteers immunized with irradiated Plasmodium falcip arum sporozoites recognize liver and blood stage malaria antigens. J. Immunol., 155, 4072–4077.
95. Kumar, S., Miller, L., Quakyi, I., Keister, D., Houghten, R., Maloy, W. et al. (1988). Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum. Nature, 334, 258–260.
96. Kumar, A, Arora, R., Kaur, P., Chauhan, VS. and Sharma, P. (1992). “Universal” T helper cell determinants enhance immunogenicity of a Plasmodium falcip arum merozoite surface antigen peptide. J. Immunol., 148, 1499–1505.
97. Lal, AA., de la Cruz, V.F., Welsh, J.A. Charoenvit, Y., Maloy, W.L. and McCutchan, T.F. (1987a). Structure of the gene encoding the circumsporozoite protein of Plasmodium yoelii. A rodent model for examining antimalarial sporozoite vaccines. J. Biol. Chem., 262, 2937–2940.
98. Lal, AA., de la Cruz, V.F., Good, M. Weiss, W.R., Lunde, M., Maloy, W.L. et al. (1987b). In vivo testing of subunit vaccine against malaria sporozoites using a rodent system. PNAS, 84, 8647–8651.
99. Lal, A.A. and Goldman, I.E (1991). Circumsporozoite protein gene from Plasmodium reichenowi, aPfalciparum-like malaria parasite: An approach in the identification of epitopes for malaria vaccine development? J. Biol. Chem., 266, 6686–6689.
100. Langeveld, J.P., Casal, J.I, Osterhaus, A.D., Cortes, E., de Swart, R., Vela, C. et al. (1994). First peptide vaccine providing protection against viral infection in the target animal: studies of canine parvovirus in dogs. J. Virol., 68, 4506–4513.
101. Langeveld, J.P., Kamstrup, S., Uttenthal, A, Strandbygaard, B., Vela, C., Dalsgaard, K et al. (1995). Full protection in mink against mink enteritis virus with new generation canine parvovirus vaccines based on synthetic peptide or recombinant protein. Vaccine, 13, 1033–1037.
102. Lex, A, Wiesmuller, K-H., Jung, G. and Bessler, W.G. (1986). A synthetic analogue of Escherichia coli lipoprotein, tripalmitoyl pentapeptide, constitutes a potent immune adjuvant. J. Immunol., 137, 2676–2681.
103. Li, S., Rodrigues, M., Rodriguez, D., Rodriguez, J.R., Esteban, M., Palese, P. et al. (1993). Priming with recombinant influenza virus followed by adminstration of recombinant vaccinia virus induces CD8+ T cell mediated protective immunity against malaria. PNAS, 90, 5214–5218.
104. Livingston, B.D., Crimi, C., Grey, H., Ishioka, G., Chisari, F.V., Fikes, J. et al. (1997). The hepatitis B virus specific CTL responses induced in humans by lipopeptide vaccination are comparable to those elicited by acute viral infection. J. Immunol., 159, 1383–1392.
105. Lockyer, M., Marsh, K and Newbold, C. (1989). Wild isolates of Plasmodium falciparum show extensive polymorphism in T cell epitopes of the circumsporozoite protein. Mol. Biochem. Parasitol., 37, 275–280.
106. Londono, J.A., Gras-Masse, H., Dubeaux, C., Tartar, A. and Druilhe, P. (1990). Secondary structure and immunogenicity of hybrid synthetic peptides derived from two Plasmodium falciparum pre-erythrocytic antigens. J. Immunol., 145, 1557–1563.
107. Lowell, G.H., Ballou, W.R Smith, L.F, Wirtz, RA., Zollinger, W.D. and Hockmeyer, W.T. (1988). Proteosome-lipopeptide vaccines: Enhancement of immunogenicity for malaria CS peptides. Science, 240, 800–802.
108. Malik, A., Egan, J.E., Houghten, R.A., Sadoff, J.C. and Hoffman, S.L. (1991). Human cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. PNAS, 88, 3300–3304.
109. Maheshwari, R.K., Czarniecki, C.W., Dutta, G.P., Puri, S.K, Dhawan, B.N. and Friedman, R.M. (1986). Recombinant human gamma interferon inhibits simian malaria. Inject. Immun., 53, 628–630.
110. McCarthy, V.C. and Clyde, D.F (1977). Plasmodium vivax: Correlation of circumsporozoite precipitation (CSP). reaction with sporozoite-induced protective immunity in man. Exp. Parasitol., 41, 167–171.
111. McCutchan, T.F, Kissinger, J.C., Touray, M.G., Rogers, M.J., Li, J., Sullivan, M. et al. (1996). Comparison of circumsporozoite proteins from avian and mammalian malarias: biological and phylogenetic implications. PNAS, 93, 11889–11894.
112. Mellouk, S., Lunel, F, Sedegah, M., Beaudoin, R.L. and Druilhe, P. (1990). Protection against malaria induced by irradiated sporozoites. Lancet, 335, 721.
113. Mellouk, S., Green, S., Nacy, C. and Hoffman, S. (1991). IFN gamma inhibits development of Plasmodium berghei exoerythrocytic stages in hepatocytes by an L-arginine-dependent effector mechanism. J. Immunol., 146, 3971–3976.
114. Men, Y., Gander, B., Merkle H. and Corradin, G. (1996). Induction of sustained and elevated immune responses to weakly immunogenic synthetic malarial peptides by encapsulation in biodegradable polymer microspheres. Vaccine, 14, 1442–1450.
115. Menard, R, Sultan, A.A., Cortes, C., Altszuler, R, van Dijk, M.R, Janse, C.J. et al. (1997). Circumsporozoite protein is required for development of malaria sporozoites in mosquitoes. Nature, 385, 336–340.
116. Merrifield, RB. (1963). Solid-phase peptide synthesis. The synthesis of a tetrapeptide. J. Am. Chem. Soc., 85, 2149–2455.
117. Metzger, J.W., Sawyer, W.H., Wille, B., Biesert, L., Bessler, W.G. and Jung, G. (1993). Interaction of immunologically-active lipopeptides with membranes. Biochim. Biophys. Acta, 1149, 29–39.
118. Migliorini, P., Betschart, B. and Corradin, G. (1993). Malaria vaccine: immunization of mice with a synthetic T cell helper epitope alone leads to protective immunity. Eur. J. Immunol., 23, 582–585.
119. Miller, M.A., Skeen, M.J. and Ziegler, H.K (1997). A synthetic peptide administered with IL-12 elicits immunity to Listeria monocytogenes. J. Immunol., 159, 3675–3679.
120. Moreno, A., Clavijo, P., Edelman, R, Davis, J., Sztein, M., Herrington, D. and Nardin, E. (1991). Cytotoxic CD4+ T cells from a sporozoite immunized volunteer recognize the Plasmodium falciparum CS protein. Int. Immunol., 3, 997–1003.
121. Moreno, A, Clavijo, P., Edelman, R, Davis, J., Sztein, M., Sinigaglia, F et al. (1993). CD4+ T cell clones obtained from Plasmodiumfalciparum sporozoite-immunized volunteers recognize polymorphic sequences of the circumsporozoite protein. J. Immunol., 151, 489–499.
122. Moreno, C.A, Rodriguez, R.J., Oliveira, G.A., Calvo-Calle, J.M. and Nardin, E.H. Immunogenicity of Plasmodium falciparum (T1B)4 MMAP vaccine in Aotus monkeys. (In preparation).
123. Mukherji, B., Chakraborty, N.G., Yamasaki, S., Okino, T., Yamase, H., Sporn, J.R. et al. (1995). Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells. PNAS, 92, 8078–8082.
124. Muller, H.M., Reckman, I., Hollingdale, M., Bujard, H., Robson, K. and Crisanti, A (1993). Thrombospondin related anonymous protein (TRAP) ofPlasmodiumfalciparum binds specifically to sulphated glycoconjugates and to Hep G2 hepatoma cells, suggesting a role for this molecule in sporozoite invasion of hepatocytes. EMBO J., 12, 2881–2889.
125. Munesinghe, D.Y., Clavijo, P., Calvo-Calle, J.M., Nussenzweig, RS. and Nardin, E. (1991). Immunogenicity of multiple antigen peptides (MAP) containing T and B cell epitopes of the repeat region of the Plasmodium falciparum circumsporozoite protein. Eur. J. Immunol., 21, 3015–3020.
126. Nardelli, B., Lu, Y.-A., Shiu, D.R., Delpierre-Defoort, C., Profy, A.T. and Tam, J.P. (1992). A chemically defined synthetic vaccine model for HIV-I. J. Immunol., 148, 914–920.
127. Nardelli, B., Haser, P.B. and Tam, J.P. (1994). Oral adminstration of an antigenic synthetic lipopeptide (MAP-P3C) evokes salivary antibodies and systemic humoral and cellular responses. Vaccine, 12, 1335–1339.
128. Nardin, E.H., Nussenzweig, RS., McGregor, I.A and Bryan, J.H. (1979). Antibodies to sporozoites: their frequent occurrence in individuals living in an area of hyperendemic malaria. Science, 206, 597–599.
129. Nardin, E.H., Nussenzweig, V., Nussenzweig, RS., Collins, W.E., Harinasuta, K.T., Tapchaisri, P. et al. (1982). Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J. Exp. Med., 156, 20–30.
130. Nardin, E.H., Clavijo, P., Mons, B., van Belkum, A., Ponnudurai, T. and Nussenzweig, R. (1991). T cell epitopes of the circumsporozoite protein of Plasmodium vivax: Recognition by lymphocytes of a sporozoite immunized chimpanzee. J. Immunol., 146, 1674–1678.
131. Nardin, E.H., Herrington, D.A., Davis, J., Levine, M., Stuber, D., Takacs, B. et al. (1989). Conserved repetitive epitope recognized by CD4+ clones from a malaria-immunized volunteer. Science, 246, 1603–1606.
132. Nardin, E.H., Oliveira, G.A, Calvo-Calle, J.M. and Nussenzweig, R. (1995). The use of multiple antigen peptides in the analysis and induction of protective immune responses against infectious diseases. Adv. Immunol., 60, 105–149.
133. Nardin, E.H., Calvo-Calle, J.M., Oliveira, G.A, Clavijo, P., Nussenzweig, RS., Simon, R, Zeng, W. and Rose, K. (1998). Plasmodium falciparum polyoximes: highly immunogenic synthetic vaccines constructed by chemoselective ligation of repeat B-cell epitopes and a universal T-cell epitope of CS protein. Vaccine, 16, 590–599.
134. Nino, J., Slierengent, B., Waters, A and Nardin, E.H. T cell responses in Plasmodium falciparum sporozoite immunized chimpanzees, in preparation.
135. Nixon, D.F., Hioe, C., Chen, P.-D., Bian, X., Kueblers, P., Li, M.L. et al. (1996). Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity. Vaccine, 14, 1523–1530.
136. Nudelman, S., Renia, L., Charoenvit, Y., Yuan, L., Miltgen, F., Beaudoin, R.L. et al. (1989). Dual action of anti-sporozoite antibodies in vitro. J. Immunol., 143, 996–1000.
137. Nussenzweig, RS., Vanderberg, J., Most, H. and Orton, C. (1967). Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. Nature, 216, 160–162.
138. Nussenzweig, R, Vanderberg, J. and Most, H. (1969). Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. IV. Dose response, specificity and humoral immunity. Milit. Med., 134, 1176–1182.
139. Nussenzweig, V. and Nussenzweig, RS. (1989). Rationale for the development of an engineered sporozoite malaria vaccine. Adv. Immunol., 45, 283–334.
140. Nussler, A., Drapier, J.C., Renia, L., Pied, S., Miltgen, F., Gentilini, M. et al. (1991). L-Arginine dependent destruction of intrahepatic malaria parasites in response to tumor necrosis factor and/or interleukin 6 stimulation. Eur. J. Immunol., 21, 227–230.
141. O'Hern, P.A., Bambra, D.S., Isahakia, M. and Goldberg, E. (1995). Reversible contraception in female baboons immunized with a synthetic epitope of sperm specific lactate dehydrogenase. Biol. Reprod., 52, 331–339.
142. Orjih, AU., Cochrane, AH. and Nussenzweig, RS. (1982). Comparative studies on the immunogenicity of infective and attenuated sporozoites of Plasmodium berghei. Trans. Roy. Soc. Trap. Med. Hyg., 76, 5761.
143. Panina-Bordignon, P., Tan, A, Termijtelen, A, Demotz, S., Corradin, G. and Lanzavecchia, A. (1989). Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells. Eur. J. Immunol., 19, 2237–2242.
144. Pessi, A, Valmori, D., Migliorini, P., Tougne, C., Bianchi, E., Lambert, P. H. et al. (1991). Lack ofH-2 restriction of the Plasmodium falciparum (NANP) sequence as multiple antigen peptide. Eur. J. Immunol., 21, 2273–2276.
145. Pied, S., Civas, A, Berlot-Picard, E, Renia, L., Miltgen, E, Gentilini, M et al. (1992). 11–6, induced by ILl, inhibits malaria pre-erythrocytic stages, but its secretion is down regulated by the parasite. J. Immunol., 148, 197–201.
146. Ponnudurai, T, Lensen, AH., van Gernert, G.J., Bolmer, M.G. and Meuwissen, J.H. (1991). Feeding behaviour and sporozoite ejection by infected Anopheles stephensi. Trans. Roy. Soc. of Trop. Med. Hyg., 85, 17580.
147. Potocnjak, P., Yoshida, N., Nussenzweig, R.S. and Nussenzweig, V. (1980). Monovalent fragments (Fab) of monoclonal antibodies to a sporozoite surface antigen (Pb44) protect mice against malaria infection. J. Exp. Med., 151, 1504–1513.
148. Qari, S.H., Goldman, I.E, Povoa, MM., Oliveira, S., Alpers, M.P. and Lal, AA. (1991). Wide distribution of the variant form of the human malaria parasite Plasmodium vivax. J. Biol. Chem., 266, 16297–16300.
149. Raddrizzani, L., Sturniolo, T, Guenot, J. Bono, E., Gallazzi, P., Nagy, Z.A et al. (1997). Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires. J. Immunol., 159, 703–711.
150. Ramasamy, R., Wijesundere, D.A., Nagendran, K. and Ramasamy, M.S. (1995). Antibody and clinical responses in volunteers to immunization with malaria peptide-diptheria toxoid conjugates. Clin. Exp. Immunol., 99, 168–174.
151. Reed, R.C., Louis-Wileman, V., Wells, R.L., Verheul, A.M., Hunter, R.L. and Lal, A.A. (1996). Re-investigation of the circumsporozoite protein based induction of sterile immunity against Plasmodium berghei infection. Vaccine, 14, 828–836.
152. Reickmann, K.H., Beaudoin, R.L., Cassells, J. and Sell, K. (1979). Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria. Bull. WHO, 57. Suppl I, 261–265.
153. Renggli, J., Valmori, D., Romero, J.F., Eberl, G., Romero, P., Betschart, B. et al. (1995). CD8+ T cell protective immunity induced by immunization with Plasmodium berghei CS protein-derived synthetic peptides: evidence that localization of peptide-specific CTLs is crucial for protection against malaria. Immunol. Lett. 46, 199–205.
154. Renia, L., Marussig, M.S., Grillot, D., Pied, S., Corradin, G., Miltgen, F. et al. (1991). In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide. PNAS, 88, 7963–7967.
155. Renia, L., Grillot, D., Marussig, M., Corradin, G., Miltgen, E, Lambert, P. et al. (1993). Effector functions of circumsporozoite peptide-primed CD4+ T cell clones against Plasmodium yoelii liver stages. J. Immunol., 150, 1471–1478.
156. Ressing, M.E., Offringa, R., Toes, R.E.M., Ossendorp, E, de Jong, J.H., Brandt, R.M.P. et al. (1996). Immunotherapy of cancer by peptide based vaccines for the induction of tumor specific T cell immunity. Immunotech., 2, 241–251.
157. Reynolds, S.R., Dahl, C.E. and Ham, D.A. (1994). T and B epitope determination and analysis of multiple antigenic peptides for the Schistosoma mansoni experimental vaccine triose-phosphate isomerase. J. Immunol., 152, 193–200.
158. Riggs, M.W., Stone, AL., Yount, P.A., Langer, R.C., Arrowood, M.J. and Bentley, D.L. (1997). Protective monoclonal antibody defines a circumsporozoite-like glycoprotein exoantigen of Cryptosporidium parvum sporozoites and merozoites. J. Immunol., 158, 1787–1795.
159. Riley, E., Allen, S., Bennett, S., Thomas, P., O’Donnell, A, Lindsay, S. et al. (1990), Recognition of dominant T cell-stimulating epitopes from the circumsporozoite protein of Plasmodium falciparum and relationship to malaria morbidity in Gambian children. Trans. Roy. Soc, of Trop. Med. Hyg., 84, 648–57.
160. Ritu, G. and Rao, D.N. (1992). Construction of synthetic immunogens: Use of T- and B-cell epitopes of CS and RESA proteins of Plasmodium falciparum. Vaccine, 10, 761–765.
161. Robson, K.J.H., Hall, J.R.S., Jennings, M.W., Harris, T.J.R., Marsh, K., Newbold, C. I. et al. (1988). A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite. Nature, 335, 79–82.
162. Robson, K.J.H., Hall J.R., Davis, L.C., Crisanti, A, Hill, A.V. and Wellems, TE. (1990). Polymorphism of the TRAP gene of Plasmodium falciparum. Proc. Roy. Soc., B, 242, 205–216.
163. Robson, K. J., Frevert, U., Reckman, I., Cowan, G., Beier, J., Scragg, I.G. et al. (1995). Thrombospondin-related adhesive protein (TRAP) of Plasmodium falciparum: expression during sporozoite ontogeny and binding to human hepatocytes. EMBO J., 14, 3883–3894.
164. Rodrigues, E.G., Zavala, E, Eichinger, D., Wilson, J.M. and Tsuji, M. (1997). Single immunizing dose of recombinant Adenovirus efficiently induces CD8+ T cell mediated protective immunity against malaria, J. Immunol., 158, 1268–1274.
165. Rodrigues, M.M., Cordey, A.S., Arreaza, G., Corradin, G., Romero, P., Maryanski, J.L. et al. (1991). CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria. Int. Immunol., 3, 579–585.
166. Rodrigues, M., Nussenzweig, R, Romero, P. and Zavala, F. (1992). The in vivo cytotoxic activity of CD8+ T cell clones correlates with their levels of expression of adhesion molecules. J. Exp. Med., 175, 895–905.
167. Rodrigues, M., Nussenzweig, RS. and Zavala, F. (1993). The relative contribution of antibodies, CD4+ and CD8+ T cells to sprozoite induced protection against malaria. Immunology, 80, 1–5.
168. Rogers, w., Malik, A., Mellouk, A., Nakamura, K., Rogers, M.D., Szarfman, A. et al. (1992). Characterization of PlasmodiumJalciparum sporozoite surface protein 2. PNAS, 89, 9176–9180.
169. Romero, P., Maryanski, J.L., Corradin, G., Nussenzweig, RS., Nussenzweig, V. and Zavala, F. (1989). Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature, 341, 323–326.
170. Romero, P., Eberl, G., Casanova, J.L., Cordey, AS., Widmann, C., Luescher, I. et al. (1992). Immunization with synthetic peptides containing a defined malaria epitope induces a highly diverse cytotoxic T lymphocyte response. J. Immunol., 148, 1871–1878.
171. Rose, K (1994). Facile synthesis of homogeneous artificial proteins. J. Am. Chem. Soc., 116, 30–33.
172. Rosenberg, R, Wirtz, R.A., Lanar, D.E., Sattabongkot, J., Hall, T., Waters, AP. et al. (1989). Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax. Science, 245, 973–976.
173. Rosenberg, R., Wirtz, RA., Schneider, I. and Burge, R (1990). An estimation of the number of malaria sporozoites ejected by a feeding mosquito. Trans. Roy. Soc. of Trop. Med. Hyg., 84, 209–212.
174. Saul, A, Lord, R, Jones, G.L., and Spencer, L. (1992). Protective immunization with invariant peptides of the Plasmodium falciparum antigen MSA2. J. Immunol., 148, 208–211.
175. Sauzet, J.P., Gras-Masse, H., Guillet, J.G. and Gomard, E. (1996). Influence of strong CD4+ T cell epitope on long-term virus-specific cytotoxic T cell responses induced in vivo with peptides. Int. Immunol., 8, 457–465.
176. Scarselli, E., Tolle, R, Koita, O., Diallo, M., Muller, H.M. Fruh, K et al. (1993). Analysis ofthe human antibody response to Thrombospondin-Related Anonymous Protein of Plasmodium falciparum. Infect. Immun., 61, 3490–3495.
177. Scheller, L.F., Wirtz, RA and Azad, AF. (1994). Susceptibility of different strains of mice to hepatic infection with Plasmodium berghei. Infect. Immun., 62, 4844–4847.
178. Scheller, L.F. and Azad, A.F. (1995). Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites. PNAS, 92, 4066–4068.
179. Schild, H., Deres, K, Wiesmuller, K.-H., Jung, G. Rammensee, H.-G. (1991). Efficiency of peptides and lipopeptides for in vivo priming of virus specific cytotoxic T cells. Eur. J. Immunol., 21, 2649–2654.
180. Schofield, L., Villaquiran, J., Ferreira, A, Schellekens, H., Nussenzweig, RS. and Nussenzweig, V. (1987). Gamma interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites. Nature, 330, 664–666.
181. Schofield, L., Ferreira, A., Altszuler, R, Nussenzweig, R and Nussenzweig, V. (1987). Interferon-gamma inhibits the intrahepatocytic development of malaria parasites in vitro. J. Immunol., 139, 2020–2025.
182. Schulz, M., Zinkernagel, R.M. and Hengartner H. (1991). Peptide-induced antiviral protection by cytotoxic T cells. PNAS, 88, 991–993.
183. Schutze, M.-P., Leclerc, C., Jolivet, M., Audibert, F. and Chedid, L. (1985). Carrier-induced epitopic suppression, a major issue for future synthetic vaccines. J. Immunol., 135, 2319–2322.
184. Sedegah, M., Sim, K.L., Mason, C., Nutman, T., Malik, A., Roberts, C. et al. (1992). Naturally acquired cytotoxic T lymphocytes against the Plasmodium falciparum circumsporozoite protein. J. Immunol., 149, 966–971.
185. Sedegah, M., Hedstrom, R, Hobart, P. and Hoffman, S.L. (1994). Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein. PNAS, 91, 9866–9870.
186. Seguin, M.C., Ballou, W.R and Nacy, C.A. 1989. Interactions of Plasmodium berghei sporozoites and murine Kupffer cells in vitro. J. Immunol., 143, 1716–1722.
187. Seguin, M., Klotz, F., Schneider, I., Weir, J.P., Goodbary, M., Slayter, M. et al. (1994). Induction of nitric oxide synthase protects against malaria in mice exposed to irradiated Plasmodium berghei infected mosquitoes: Involvement of interferon gamma and CD8+ T cells. J. Exp. Med., 180, 353–358.
188. Sette, A., Vitiello, A., Reherman, B., Fowler, P., Nayersina, R., Kast, W.M. et al. (1994). The relationship between class I binding affinity and immunogenicity of cytotoxic T cell epitopes. J. Immunol., 153, 5586–5592.
189. Shanna, P., Bharadwaj, A., Bhasin, V.K., Sailaja, V.N. and Chauhan, V.S. (1996). Antibodies to a conserved-motif peptide sequence of the Plasmodium falciparum thrombospondin related anonymous protein and circumsporozoite protein recognize a 78 kilodalton protein I the asexual blood stages of the parasite and inhibit merozoite invasion in vitro. Infect. Immun., 64, 2172–2179.
190. Sharrna, P., Kumar, A., Batni, S. and Chauhan, V.S. 1993. Co-dominant and reciprocal T helper cell activity ofepitopic sequences and fonnation of junctional B cell determinants in synthetic T:B chim eric immunogens. Vaccine, 11, 1321–1326.
191. Shin, S.C.J., Vanderberg, J.P. and Terzakis, J.A. (1982). Direct infection of hepatocytes by sporozoites of Plasmodium berghei. J. Protozool., 29, 448–454.
192. Sidney, J., Grey, H.M., Kubo, R.T and Sette, A (1996). Practical, biochemical and evolutionary implications of the discovery of HLA class I supernotifs. Immunol. Today 17, 261–266.
193. Sinigaglia, E, Guttinger, M., Kilgus, J., Doran, D.M., Matile, H., Etlinger, H. et al. (1988). A malaria T-cell epitope recognized in association with most mouse and human MHC class II molecules. Nature, 336, 778780.
194. Sinigaglia, G. and Hammer, J. (1995). Motifs and supennotifs for MHC class II binding peptides. J. Exp. Med., 181, 449–451.
195. Sinnis, P., Clavijo, P., Fenyo, D., Chait, B.T., Cerami, C. and Nussenzweig, V. (1994). Structural and functional properties of region II plus of the malaria circumsporozoite protein. J. Exp. Med., 180, 297–306.
196. Spitalny, G.L and Nussenzweig, R.S. (1972). Effect of various routes of immunization and methods of parasite attenuation on the development of protection against sporozoite-induced rodent mal aria. Proc. Helminthol. Soc., 39. 506–514.
197. Stewart, MJ. and Vanderberg, J.P. (1992). Electron microscopic analysis of circumsporozoite protein trail formation by gliding malaria sporozoites. J. Protozool., 39, 663–671.
198. Stewart, M., Nawrot, R., Schulman, S., Vanderberg, J.P. (1986). Plasmodium berghei sporozoite invasion is blocked in vitro by sporozoite immobilizing antibodies. Infect. Immun., 51, 859–864.
199. Stoute, J.A., Siaoui, M., Heppner, D.G., Momin, P., Keser, K.E., Desmons, P. et al. (1997). A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS, S Malaria Vaccine Evaluation Group. New Eng. J. Med., 336, 86–91.
200. Sultan, A, Thathy, V, Frevert, U., Robson, K.J.H., Crisanti, A., Nussenzweig, V. et al. (1997). TRAP is necessary for gliding motility and infectivity of Plasmodium sporozoites. Cell, 90, 1–12.
201. Takita-Sonoda, Y, Tsuji, M., Kamboj, K., Nussenzweig, R.S., Calvijo, P. and Zavala, E (1996). Plasmodium yoelii: Peptide immunization induces protective CD4+ T cells against a previously unrecognized cryptic epitope of the circumsporozoite protein. Exp. Parasitol., 84, 223–230.
202. Tam, J.P. (1988). Synthetic peptide vaccine design: Synthesis and properties of a high-density multiple antigenic peptide system. PNAS, 85, 5409–5413.
203. Tam, J.P. and Lu, Y.-A. (1989). Vaccine engineering: enhancement of immunogenicity of synthetic peptide vaccines related to hepatitis in chemically defined models consisting of T- and B-cell epitopes. PNAS, 86, 9084–9088.
204. Tam, J.P., Clavijo, P., Lu, YA, Nussenzweig, V., Nussenzweig, R. and Zavala, F. (1990). Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malaria. J. Exp. Med., 171, 299–306.
205. Tam, J.P. (1996). Recent advances in multiple antigen peptides. J. Immunol. Meth., 196, 17–32.
206. Tapchaisri, P., Chomcham, Y, Poonthong, C, Asavanigh, A., Limsuwan, S., Maleevan, O. et al. (1983). Anti-sporozoite antibodies induced by natural infection. Am. J. Trop. Med. Hyg., 32, 1203–1208.
207. Tourdot, S., Oukka, M., Manuguerra, J.C., Magafa, V, Vergnon, 1., Riche, N. et al. (1997), Chimeric Peptides: A new approach to enhancing the immunogenicity of peptides with low MHC class I affinity. Application in antiviral vaccination. J. Immunol., 159, 2391–2398.
208. Trottein, E, Triglia, T. and Cowman, A.E (1995). Molecular cloning of a gene from Plasmodium falciparum that codes for a protein sharing motifs found in adhesive molecules from mammals and plasmodia. Mol. Biochem. Parasitol., 74, 129–141.
209. Tsuji, M., Romero, P, Nussenzweig, R. and Zavala, E (1990). CD4+ cytolytic T cell clone confers protection against murine malaria. J. Exp. Med., 172, 1353–1357.
210. Tsuji, M., Miyahira, Y, Nussenzweig, R.S., Aguet, M., Reichel, M. and Zavala, E. (1995). Development of antimalaria immunity in mice lacking IFN-ganima receptor. J. Immunol., 154, 5338–5344.
211. Valmori, D., Pessi, A., Bianchi, E. and Corradin, G. (1992). Use of human universally antigenic tetanus toxin T cell epitopes as carriers for human vaccination. J. Immunol., 149, 717–721.
212. Valmori, D., Romero, J., Men, Y., Mayanski, J., Romero, P. and Corradin G. (1994). Induction of a cytotoxic T cell response by co-injection of a Th peptide and a CTL peptide in IFA: further enhancement by preinjection of IFA alone. Eur. J. Immunol., 24, 1458–1462.
213. Vanderberg, J.P., Nussenzweig, R.S., Most, H. and Orton, C.G. (1968). Protective immunity produced by the injection of X-irradiated sporozoites of Plasmodium berghei. II Effects of radiation on sporozoites. J. Parasitol., 54, 1175–1180.
214. Vanderberg, J.P., Nussenzweig, R. and Most, H. (1969). Protective immunity produced by injections of X-irradiated sporozoites of Plasmodium berghei. V. In vitro effects of immune serum on sporozoites. Milit. Med., 134, Suppl., 1183–1190.
215. Vanderberg, J.P., Nussenzweig, R.S. and Most, H. (1970). Protective immunity produced by the bite of X-irradiated mosquitoes infected with Plasmodium berghei. J. Parasitol., 56, 350–351.
216. Vanderberg, J., Chew, S. and Stewart, MJ. (1990). Plasmodium sporozoite interactions with macrophages in vitro: a videomicroscopic analysis. J. Protozool., 37, 28–36.
217. van der Burg, S.H., Visseren, M.J.W., Brandt, R.M.P., Kast, W.M. and Melief, C.J.M. (1996). Immunogenicity of peptides bound to MHC class I molecules depends on the MHC peptide complex stability. J. Immunol., 156, 3308–3314.
218. Van Elas, A., van der Burg, A.H., van der Minne, C.E., Borghi, M., Mourer, J.S., Melief, CJM. et al. (1996). Peptide pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201 binding peptides from the Melan-A/MART-1 self antigen. Eur. J. Immunol., 26, 1683–1689.
219. Verheul, A.F, Udhayakumar, V, Jue, D.L., Wohlhueter, R.M. and Lal, A.A. (1995). Manopalmitic acid-peptide conjugates induce cytotoxic T cell responses against malarial epitopes: importance of spacer amino acids. J. Immunol. Meth., 182, 219–226.
220. Vitiello, A., Ishioka, G., Grey, H.M., Rose, R., Farness, P., LaFond, R. et al. (1995). Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection I. Induction of a primary cytotoxic T lymphocyte response in humans. J. Clin. Invest., 95, 341–349.
221. Walker, C., Selby, M., Erickson, A., Cataldo, D., Valensi, J.P. and Van Nest, G. (1992). Cationic lipids direct a viral glycoprotein into the class I major histocompatibility complex antigen-presentation pathway. PNAS, 89, 7915–7918.
222. Wang, R., Charoenvit, Y., Corradin, G., Porrozzi, R., Hunter, R.L., Glenn, G. etal. (1995). Induction ofprotective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine. J. Immunol., 154, 2784–2793.
223. Wang, R., Charoenvit, Y., Corradin, G., De la Vega, P., Franke, E.D. and Hoffman, S.L. (1996a). Protection against malaria by Plasmodium yoelii sporozoite surface protein 2 linear peptide induction of CD4+ T cell- and IFN-y dependent elimination of infected hepatocytes. J. Immunol., 157, 4061–4067.
224. Wang, R., Charoenvit, Y., Daly, T.M., Long, C.A., Corradin, G. and Holman, S.L. (1996b). Protective efficacy against malaria of a combination sporozoite and erythrocytic stage vaccine. Immunol. Lett., 53, 83–93.
225. Watari, E., Dietzschold, B., Szokan, G. and Heber-Katz, E. (1987). A synthetic peptide induces long-term protection from lethal infection with herpes simplex virus 2. J. Exp. Med., 165, 459–470.
226. Weber, J.L. and Hockmeyer, W.T. (1985). Structure of the circumsporozoite protein gene in 18 strains of Plasmodium falciparum. Mol. Biochem. Parasitol., 15, 305–310.
227. Weber, J.L., Egan, J.E., Lyon, J.A., Wirtz, R.A., Charoenvit, Y., Maloy, W.L. et al. (1987). Plasmodium berghei: Cloning of the circumsporozoite protein gene. Exp. Parasitol., 63, 295.
228. Weiss, W.R., Sedegah, M., Beaudoin, R.L., Miller, L.H. and Good, M. (1988). CD8+ T cells (cytotoxic/suppressors) are required for protection in mice immunized with malaria sporozoites. PNAS, 85, 573–576.
229. Weiss, w., Good, M., Hollingdale, M., Miller, L. and Berzofsky, J. (1989). Genetic control of immunity to Plasmodium yoelii sporozoites. J. Immunol., 143, 4263–4266.
230. Weiss, W.R., Mellouk, S., Houghten, R.A., Sedegah, M., Kumar, S., Good, M.F et al. (1990). Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes. J. Exp. Med., 171, 763–773.
231. White, K.L., Snyder, H.L. and Krzych, U. (1996). MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei. J. Immunol., 156, 3374–3381.
232. Widman, C., Maryanski, J.L., Romero, P. and Corradin, G. (1991). Differential stability of antigenic MHC class I restricted synthetic peptides. J. Immunol., 147, 3745–3750.
233. Widman, C, Romero, R, Maryanski, J. Corradin, G, and Valmori, D, (1992). T helper epitopes enhance the cytotoxic response of mice immunized with MHC class I-restricted malaria peptides. J. Immunol. Meth., 155, 95–99.
234. Wiesmuller, K-H., Jung, G., Gillessen, D., Loffl, C, Bessler, W.G. and Boltz, T. (1991). The antibody response in BALB/C mice to the Plasmodium falciparum circumsporozoite repetitive epitope covalently coupled to synthetic lipopeptide adjuvant. Immunology, 72, 109–113.
235. Wizel, B., Rogers, W.O., Houghten, R., Lanar, D., Tine, J. and Hoffman, S. (1994). Induction of murine cytotoxic T lymphocytes against Plasmodiumfalciparum sporozoite surface protein 2. Eur. J. Immunol., 24, 1487–1495.
236. Wizel, B., Houghten, R., Church, P., Tine, J.A, Lanar, D.E., Gordon, D.M. et al. (1995a). HLA-A2.1 restricted cytotoxic T lymphocyte responses to multiple Plasmodiumfalciparum sporozoite surface protein 2 epitopes in sporozoite immunized volunteers. Immunol., 155, 766–775.
237. Wizel, B., Houghten, R.A., Parker, K., Coligan, J.E., Church, P, Gordon, D.M. et al. (1995b). Irradiated sporozoite vaccine induces HLA-B8 restricted cytotoxic T lymphocyte responses against two overlapping epitopes of Plasmodium falciparum surface sporozoite protein 2. J. Exp. Med., 182, 1435–1445.
238. Wolowczuk, I., Auriault, C, Bossus, M., Boulanger, D., Gras-Masse, H., Mazingue, C. et al. (1991). Antigenicity and immunogenicity of a multiple peptidic construction of the Schistosoma mansoni Sm-28 GST antigen in rat, mouse, and monkey. J. Partial protection of Fischer rats after active immunization. J. Immunol., 146, 1987–1995.
239. Yoshida, N., Nussenzweig, R.S., Potocnjak, P., Nussenzweig, V. and Aikawa, M. (1980). Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite. Science, 207, 71–73.
240. Yoshida, N., Di Santi, S.M., Dutra, A.P., Nussenzweig, R.S., Nussenzweig, V. and Enea, V. (1987). Plasmodium falciparum: Epidemiological studies on the circumsporozoite gene. Exp. Parasitol., 71, 386–392.
241. Zavala, E, Cochrane, AH., Nardin, E.H., Nussenzweig, R.S. and Nussenzweig, V. (1983). Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes. J. Exp. Med., 157, 1947–1957.
242. Zavala, E Tam, J.P., Barr, P.J., Romero, P.J., Ley, V., Nussenzweig, R.S. et al. (1987). Synthetic peptide vaccine confers protection against murine mal aria. J. Exp. Med., 166, 1591–1596.
243. Zavala, F., Tam, J.P., Hollingdale, M.R., Cochrane, AH., Quakyi, I., Nussenzweig, R.S. et al. (1985). Rationale for development of a synthetic vaccine against Plasmodium falciparum malaria. Science, 228, 1436–1440.
244. Zavala, F. and Chai, S. (1990). Protective anti-sporozoite antibodies induced by a chemically defined synthetic vaccine. Immunol. Lett., 25, 271–274.